Market Overview:
The global self-monitoring blood glucose strips market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as rising prevalence of diabetes, increasing awareness about diabetes and its complications, technological advancements in self-monitoring blood glucose strips, and growing demand for home-based testing. However, the high cost of self-monitoring blood glucose strips may restrain the growth of this market during the forecast period. Based on type, the global self-monitoring blood glucose strips market is segmented into glucose oxidase strip, glucodehydrogenase strip, and other types of strip. The glucodehydrogenase strip segment is expected to grow at a higher CAGR than other segments during the forecast period from 2018 to 2030 owing to its advantages over other types of strips such as accuracy and faster results. Based on application, the global self-monitoring blood sugarstripsmarket is divided into hospital useage , clinic usage ,and household usage .
Product Definition:
Self-Monitoring Blood Glucose Strips (SMBG) are used to monitor blood sugar levels in people with diabetes. They allow people to test their blood sugar levels at home and track the results over time. This helps them to adjust their treatment plan as needed and maintain better control of their diabetes.
Glucose Oxidase:
Glucose oxidase is an enzyme that catalyzes the oxidation of glucose to form dehydrogenated sugar and carbon dioxide. The self-monitoring blood glucose (SMBG) strips are used for measuring the blood sugar level in humans and animals. It is one of the most common diabetes test kits available in the market today, along with hemoglobin electrophoresis, which helps detect hemoglobin A1C levels in patients suffering from type 1 or type 2 diabetes.
Glucose Dehydrogenase:
Glucose dehydrogenase (GDH) is an enzyme that catalyzes the chemical reaction between glucose and its hygroscopic inorganic by-product, hydrogen peroxidase. The presence of GDH on the strips makes them capable to measure blood sugar levels even when a patient is not eating or drinking. These factors make self-monitoring blood glucose strips one of the most popular choices for diabetes management along with insulin pumps and other devices.
Application Insights:
The global market is segmented by application into hospital, clinic and household based on the use of self-monitoring blood glucose strips. In 2016, the hospital segment dominated with a share of over 60% in terms of revenue. The growth can be attributed to increasing prevalence of diabetes coupled with rising awareness about SMBG kits among patients suffering from diabetes at hospitals and clinics.
Household based testing is expected to witness significant growth over the forecast period owing to growing awareness about early detection and management associated with HbA1c levels along with an increase in product adoption for self-monitoring purposes. Furthermore, growing demand for products that enable real-time data analysis will further boost industry growth during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to technological advancements, high prevalence of diabetes, and availability of advanced products in this region. Moreover, increasing cases of hospital-acquired infections are also driving the demand for self-monitoring blood glucose strips in this region.
Asia Pacific is anticipated to witness a lucrative growth rate over the forecast period owing to rising incidences of diabetes and other associated health issues such as kidney failure and heart attacks among others caused by high blood glucose levels (hyperglycemia). In addition, an increase in healthcare expenditure has led major players operating across various sectors including medical devices & supplies; pharmaceuticals; diagnostics; hospitals & clinics; patient support services & supplies)to expand their business operations within APAC thereby driving regional market growth over the projected time frame (2018 - 2030). For instance, Novo Nordisk A/S.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is expected to drive the demand for self-monitoring blood glucose strips in the coming years.
- Technological advancements: The self-monitoring blood glucose strip market is witnessing rapid technological advancements, which is resulting in the development of innovative products with enhanced features. This is likely to boost the demand for these strips in the near future.
- Rising awareness about diabetes and its complications: There has been a significant rise in awareness about diabetes and its complications among people across the globe in recent years. This is likely to fuel demand for self-monitoring blood glucose strips in the coming years as well, as more people would want to monitor their blood sugar levels on a regular basis..
Scope Of The Report
Report Attributes
Report Details
Report Title
Self-Monitoring Blood Glucose Strips Market Research Report
By Type
Glucose Oxidase, Glucose Dehydrogenase, Other
By Application
Hospital, Clinic, Household
By Companies
Roche Diagnostics, LifeScan, Medtronic, Abbott Laboratories, Becton Dickinson, Beurer, Animas Corporation, Bioptik Technology, DexCom, GlySens, Medisana, Menarini Diagnostics, Nemaura Medical, Nipro Diagnostics, Nova Biomedical, Owen Mumford, Senseonics, TaiDoc Technology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Self-Monitoring Blood Glucose Strips Market Report Segments:
The global Self-Monitoring Blood Glucose Strips market is segmented on the basis of:
Types
Glucose Oxidase, Glucose Dehydrogenase, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Household
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Diagnostics
- LifeScan
- Medtronic
- Abbott Laboratories
- Becton Dickinson
- Beurer
- Animas Corporation
- Bioptik Technology
- DexCom
- GlySens
- Medisana
- Menarini Diagnostics
- Nemaura Medical
- Nipro Diagnostics
- Nova Biomedical
- Owen Mumford
- Senseonics
- TaiDoc Technology
Highlights of The Self-Monitoring Blood Glucose Strips Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Glucose Oxidase
- Glucose Dehydrogenase
- Other
- By Application:
- Hospital
- Clinic
- Household
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Self-Monitoring Blood Glucose Strips Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Self-monitoring blood glucose strips are a type of test strip that can be used to measure blood sugar levels. These strips use a chemical reaction to create an electrical signal, which can be read by a device to provide information about the level of sugar in the blood.
Some of the major companies in the self-monitoring blood glucose strips market are Roche Diagnostics, LifeScan, Medtronic, Abbott Laboratories, Becton Dickinson, Beurer, Animas Corporation, Bioptik Technology, DexCom, GlySens, Medisana, Menarini Diagnostics, Nemaura Medical, Nipro Diagnostics, Nova Biomedical, Owen Mumford, Senseonics, TaiDoc Technology.
The self-monitoring blood glucose strips market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Self-Monitoring Blood Glucose Strips Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Self-Monitoring Blood Glucose Strips Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Self-Monitoring Blood Glucose Strips Market - Supply Chain
4.5. Global Self-Monitoring Blood Glucose Strips Market Forecast
4.5.1. Self-Monitoring Blood Glucose Strips Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Self-Monitoring Blood Glucose Strips Market Size (000 Units) and Y-o-Y Growth
4.5.3. Self-Monitoring Blood Glucose Strips Market Absolute $ Opportunity
5. Global Self-Monitoring Blood Glucose Strips Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Type
5.3.1. Glucose Oxidase
5.3.2. Glucose Dehydrogenase
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Self-Monitoring Blood Glucose Strips Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Household
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Self-Monitoring Blood Glucose Strips Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Self-Monitoring Blood Glucose Strips Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Self-Monitoring Blood Glucose Strips Demand Share Forecast, 2019-2026
9. North America Self-Monitoring Blood Glucose Strips Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Household
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Type
9.7.1. Glucose Oxidase
9.7.2. Glucose Dehydrogenase
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Self-Monitoring Blood Glucose Strips Demand Share Forecast, 2019-2026
10. Latin America Self-Monitoring Blood Glucose Strips Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Household
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Type
10.7.1. Glucose Oxidase
10.7.2. Glucose Dehydrogenase
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Self-Monitoring Blood Glucose Strips Demand Share Forecast, 2019-2026
11. Europe Self-Monitoring Blood Glucose Strips Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Household
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Type
11.7.1. Glucose Oxidase
11.7.2. Glucose Dehydrogenase
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Self-Monitoring Blood Glucose Strips Demand Share, 2019-2026
12. Asia Pacific Self-Monitoring Blood Glucose Strips Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Household
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Type
12.7.1. Glucose Oxidase
12.7.2. Glucose Dehydrogenase
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Self-Monitoring Blood Glucose Strips Demand Share, 2019-2026
13. Middle East & Africa Self-Monitoring Blood Glucose Strips Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Household
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Self-Monitoring Blood Glucose Strips Market Size and Volume Forecast by Type
13.7.1. Glucose Oxidase
13.7.2. Glucose Dehydrogenase
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Self-Monitoring Blood Glucose Strips Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Self-Monitoring Blood Glucose Strips Market: Market Share Analysis
14.2. Self-Monitoring Blood Glucose Strips Distributors and Customers
14.3. Self-Monitoring Blood Glucose Strips Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche Diagnostics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. LifeScan
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Medtronic
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Abbott Laboratories
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Becton Dickinson
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Beurer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Animas Corporation
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bioptik Technology
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. DexCom
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. GlySens
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Medisana
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Menarini Diagnostics
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Nemaura Medical
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Nipro Diagnostics
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Nova Biomedical
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Owen Mumford
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Senseonics
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. TaiDoc Technology
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
